glp 1 based therapies GLP-1 Drugs & What They Do UC Davis Health examines systemic

rs-fMRI correlates with the metabolic baseline Brain activity and the physiological effects resulting from it are important and diverse, and require a large amount of energy from substances such as glucose

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) effectively manage type 2 diabetes and promote weight loss, but their gastrointestinal effectsincluding nausea, vomiting, and diarrheacan disrupt fluid and electrolyte balance

Study type: analysis / commentary

10.1016/j.bbrc.2014.07.116 [DOI] [PubMed] [Google Scholar] Kishi, T

Notably, the observed variability in efficacy between agents, particularly in the early phases of treatment, emphasizes the importance of individualized therapeutic strategies, tailored to specific clinical goals, baseline metabolic profiles, and patient preferences

The cells sense amino acids the building blocks of protein and then release GLP-1 into the bloodstream